Detalles de la búsqueda
1.
Gemcitabine Modulates HLA-I Regulation to Improve Tumor Antigen Presentation by Pancreatic Cancer Cells.
Int J Mol Sci
; 25(6)2024 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38542184
2.
The role of tumor heterogeneity in immune-tumor interactions.
Cancer Metastasis Rev
; 40(2): 377-389, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33682030
3.
Major histocompatibility complex class I molecule expression by pancreatic cancer cells is regulated by activation and inhibition of the epidermal growth factor receptor.
Immunol Res
; 70(3): 371-391, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35303241
4.
The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer.
PLoS One
; 17(9): e0273518, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36126055
5.
Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of a Spontaneous Mouse Model of Pancreatic Cancer.
Cancers (Basel)
; 13(7)2021 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33810510
6.
Nanoformulation of CCL21 greatly increases its effectiveness as an immunotherapy for neuroblastoma.
J Control Release
; 327: 266-283, 2020 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32711026
7.
Correction: Major histocompatibility complex class I molecule expression by pancreatic cancer cells is regulated by activation and inhibition of the epidermal growth factor receptor.
Immunol Res
; 2023 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38051459
Resultados
1 -
7
de 7
1
Próxima >
>>